Cited by 152Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index; 11 of the 188 sources its claims cite were checked for support.

Top-down proteomics: challenges, innovations, and applications in basic and clinical research

Open access
Brown, Kyle A., Melby, Jake A., Roberts, David S., Ge, Ying·2020·Expert Review of Proteomics

Abstract

Introduction- A better understanding of the underlying molecular mechanism of diseases is critical for developing more effective diagnostic tools and therapeutics toward precision medicine. However, many challenges remain to unravel the complex nature of diseases.Areas covered- Changes in protein isoform expression and post-translation modifications (PTMs) have gained recognition for their role in underlying disease mechanisms. Top-down mass spectrometry (MS)-based proteomics is increasingly recognized as an important method for the comprehensive characterization of proteoforms that arise from alternative splicing events and/or PTMs for basic and clinical research. Here, we review the challenges, technological innovations, and recent studies that utilize top-down proteomics to elucidate changes in the proteome with an emphasis on its use to study heart diseases.Expert opinion- Proteoform-resolved information can substantially contribute to the understanding of the molecular mechanisms underlying various diseases and for the identification of novel proteoform targets for better therapeutic development . Despite the challenges of sequencing intact proteins, top-down proteomics has enabled a wealth of information regarding protein isoform switching and changes in PTMs. Continuous developments in sample preparation, intact protein separation, and instrumentation for top-down MS have broadened its capabilities to characterize proteoforms from a range of samples on an increasingly global scale.

Overview

Integrity signals

Registry

Crossref · 10.1080/14789450.2020.1855982

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

130 Not checked yet · 5 Own interpretation · 5 No basis given · 3 Supported · 2 Supported so far · 2 Partly supported · accuracy not yet measured

Verify all 177 references — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 55
  • The quote only partly states this claim. 1
71 of 71
  • The paper relies on this without support.

    Many diseases have complex molecular mechanisms that remain poorly understood.

    “However, many challenges remain to unravel the complex nature of diseases.”
  • The paper relies on this without support.

    Improved understanding of disease mechanisms is necessary for developing more effective diagnostics and therapeutics for precision medicine.

    “A better understanding of the underlying molecular mechanism of diseases is critical for developing more effective diagnostic tools and therapeutics towards precision medicine.”
  • The paper relies on this without support.

    hiPSC-CMs resemble fetal cardiomyocytes rather than fully matured cardiomyocytes.

    “However, a major limitation to hiPSC-CM resembles fetal CMs rather than fully matured CMs.”
  • The paper relies on this without support.

    There is a lack of comprehensive methods to measure the maturity of hiPSC-CMs.

    “In addition, there is a lack of comprehensive methods to measure the maturity of hiPSC-CMs.”
  • The paper relies on this without support.

    There remains an incomplete understanding of the molecular mechanism underlying sarcopenia.

    “However, there remains an incomplete understanding of the molecular mechanism underlying sarcopenia.”
  • The paper relies on this without support.

    Patient tissue samples are the most relevant for disease studies.

    “While patient tissue samples are the most relevant for disease studies, human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer unprecedented clinical opportunities to study heritable cardiovascular diseases, test various drug candidates, and enable cardiac regeneration and precision medicine [150].”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 163 references

Research works printed but not linked: 5

  1. 10.1002/pro.5560031109 · DOI · Paper page
  2. 10.1021/cr068286z · DOI · Paper page
  3. Anderson NL, 2002, History Charact Diagn Prospects, 1, 845
  4. 10.1021/pr200258m · DOI · Paper page
  5. 10.1080/14789450.2016.1209414 · DOI · Paper page

Cited by

Sorted by citations

See all 152

Metadata

Authors
Brown, K. A., Melby, J. A., Roberts, D. S., & Ge, Y.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
  • Brown, Kyle A.
  • Ge, Ying
Venue
Expert Review of Proteomics
Published
2020-10-02
Volume
17
Issue
10
Pages
719-733
ISSN
  • 1478-9450 (ISSN-L)
  • 1744-8387
OpenAlex
W3106602244
Cited by
152
References
163
Citations by year
2026: 23 · 2025: 37 · 2024: 28 · 2023: 26 · 2022: 19 · 2021: 18 · 2020: 1
FWCI
6.11
Type
journal article
Language
en
Open access
Locations
  • Expert Review of Proteomics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
Foundation for the National Institutes of Health
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
top-down proteomics, proteoforms, protein isoforms, post-translational modification, alternative splicing, heart disease, precision medicine, sample preparation, intact protein separation
MeSH terms
Heart Diseases, Humans, Protein Processing, Post-Translational, Proteomics, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review